Dermata Therapeutics
(NASDAQ) DRMA
Dermata Therapeutics Financials at a Glance
Market Cap
$5.19M
Revenue (TTM)
$0.00
Net Income (TTM)
$7.56M
EPS (TTM)
$-9.30
P/E Ratio
-0.14
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Price
$1.25
Volume
158,860
Open
$1.20
Price
$1.25
Volume
158,860
Open
$1.20
Previous Close
$1.29
Daily Range
$1.18 - $1.30
52-Week Range
$1.10 - $9.90
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Price
$1.25
Volume
158,860
Open
$1.20
Previous Close
$1.29
Daily Range
$1.18 - $1.30
52-Week Range
$1.10 - $9.90
DRMA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Dermata Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
9
CEO
Gerry Proehl, MBA
Website
www.dermatarx.comHeadquarters
San Diego, CA 92130, US
DRMA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-194%
Return on Capital
-1%
Return on Assets
-96%
Earnings Yield
-7.14%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.19M
Shares Outstanding
4.02M
Volume
158.86K
Short Interest
0.00%
Avg. Volume
2.05M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$7.77M
EBITDA
$7.77M
Operating Cash Flow
$7.76B
Capital Expenditure
$0.00
Free Cash Flow
$7.76B
Cash & ST Invst.
$7.52B
Total Debt
$0.00
Dermata Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$5.19M
N/A
Market Cap/Employee
$648.58K
N/A
Employees
8
N/A
Net Income
$1.86M
+40.9%
EBITDA
$1.90M
+39.7%
Quarterly Fundamentals
Net Cash
$7.52M
+137.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-96.12%
N/A
Return on Invested Capital
-1.25%
N/A
Free Cash Flow
$1.33M
+54.4%
Operating Cash Flow
$1.33M
+54.4%